Union Korea Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '24 Oct 10, 2024	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	19,700	19,700	15,410	35,741	51,626	78,193
Market Cap Growth	-45.97%	27.84%	-56.88%	-30.77%	-33.98%	-46.23%
Enterprise Value	51,099	38,909	36,636	69,920	79,902	92,488
Last Close Price	2725.00	2725.00	2725.00	4950.00	7150.00	10150.00
PS Ratio	0.54	0.54	0.30	0.57	0.84	1.62
PB Ratio	-0.86	-0.86	1.88	1.18	1.06	1.46
P/TBV Ratio	-	-	2.07	1.22	1.10	1.55
P/OCF Ratio	-	-	36.67	26.24	-	40.84
EV/Sales Ratio	1.40	1.07	0.71	1.11	1.30	1.92
EV/EBITDA Ratio	-	-	-	-	15.18	-
EV/EBIT Ratio	-	-	-	-	62.84	-
Debt / Equity Ratio	-0.94	-0.94	2.92	1.30	0.76	0.67
Debt / EBITDA Ratio	-	-	-	-	7.05	-
Net Debt / Equity Ratio	-0.65	-0.65	2.22	1.06	0.61	0.28
Net Debt / EBITDA Ratio	-0.69	-0.69	-1.16	-2.98	5.62	-2.31
Net Debt / FCF Ratio	-12.08	-12.08	-34.45	-35.70	-3.51	-2.81
Asset Turnover	0.60	0.60	0.61	0.61	0.53	0.45
Inventory Turnover	3.13	3.13	3.57	4.11	3.18	2.72
Quick Ratio	0.24	0.24	0.42	0.70	0.70	1.11
Current Ratio	0.34	0.34	0.63	0.84	0.93	1.36
Return on Equity (ROE)	-	-	-108.57%	-46.00%	-1.82%	-18.22%
Return on Assets (ROA)	-24.15%	-24.15%	-13.77%	-8.87%	0.69%	-6.14%
Return on Invested Capital (ROIC)	-2732.56%	-253.70%	-41.95%	-20.87%	-1.71%	-14.26%
Return on Capital Employed (ROCE)	129.00%	129.00%	-171.00%	-41.50%	2.40%	-14.00%
Earnings Yield	-156.44%	-156.44%	-135.73%	-50.80%	-1.80%	-14.21%
FCF Yield	-6.24%	-6.24%	-3.43%	-2.52%	-16.33%	-6.72%
Buyback Yield / Dilution	-0.03%	-0.03%	-0.09%	2.14%	5.05%	-16.95%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.